Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
BioCryst Pharmaceuticals, Inc.
(NQ:
BCRX
)
1.590
USD
-0.070 (-4.22%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 24, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about BioCryst Pharmaceuticals, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Modestly Higher Close On Upbeat Earnings
January 11, 2013
The markets closed modestly higher with the Dow gaining 17 points to 13,488 as investors weighed upbeat earnings news against a widening trade deficit. Nasdaq rose 3 points to 3125.
Read More
category
Market News
from
MarketMinute.com Market Updates
BioCryst Pharmaceuticals Up 9.8%, Shares Break Through Resistance (BCRX)
January 11, 2013
from
Comtex SmarTrend® News Briefs
Elite Traders Group Issues Watch Alert on Micro-Cap Stocks with Momentum
January 04, 2013
category
AGRICULTURE
,
NUTRITION
,
RELIGION
, and 128 more.
from
Latest eTeligis Press Releases with 'Plus' ranking
Benzinga's Small Cap Movers for Wednesday January 2, 2013
January 02, 2013
Below are highlights from Benzinga's daily coverage of small cap securities making big moves: Gevo Shares of Gevo (NASDAQ: GEVO ), the Englewood, CO renewable chemicals and next-generation biofuels...
Read More
category
Benzinga
,
US78461U1016
,
Movers
, and 13 more.
from
Latest Articles from Benzinga.com
Downgrade Alert for BioCryst Pharmaceuticals (BCRX)
December 12, 2012
from
Comtex SmarTrend® News Briefs
Biotech Movers: A Tough Week All Around
December 10, 2012
Read More
category
NASDAQ:SRPT
,
NASDAQ:BCRX
,
NASDAQ:ACRX
, and 3 more.
from
InvestorPlace - Latest Headlines
BioCryst Pharmaceuticals Announces Focused Corporate Strategy and Restructuring
December 07, 2012
BioCryst Pharmaceuticals, Inc. announced today that in response to recent events and an assessment of its assets, the Company is restructuring and implementing a focused strategy to advance its...
Read More
category
Announcement
,
Healthcare
,
Biotechnology and Drugs
from
1888PressRelease - Full Feed
BioCryst Pharma (BCRX) Announces Restructuring; to Halve Workforce
December 07, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7931563 for the full story.
Read More
from
StreetInsider.com News Articles
Unusual 11 Mid-Day Movers 12/03: (SQNS) (CLNT) (CYCC) Higher; (GMED) (BCRX) (QLGC) Lower
December 03, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7918078 for the full story.
Read More
from
StreetInsider.com News Articles
Investors look to Lighten Up on Shares of BioCryst Pharmaceuticals, Shares Down 9.9% (BCRX)
December 03, 2012
from
Comtex SmarTrend® News Briefs
Fiscal Cliff Talks Falter, Markets Mixed
December 03, 2012
Negotiations to avert the fiscal cliff appeared to falter. The markets traded mixed during the midday with the Dow losing 12 points to 13,013. Nasdaq added 4 points to 3015.
Read More
category
Market News
from
MarketMinute.com Market Updates
Friday Sector Leaders: Metals & Mining, Biotechnology Stocks
November 30, 2012
In trading on Friday, metals & mining shares were relative leaders, up on the day by about 1.9%. Leading the group were shares of Prospect Global Resources (PGRX), up about 17.4% and shares of Oxford...
Read More
category
Stocks
from
Market News Video
Hot Stock: BioCryst Pharmaceuticals, Shares Gain 25.0% (BCRX)
November 30, 2012
from
Comtex SmarTrend® News Briefs
Notable Mergers and Acquisitions of the Day 11/30: (BCRX) (KW)
November 30, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7914076 for the full story.
Read More
from
StreetInsider.com News Articles
BioCryst Pharmaceuticals, Presidio Pharmaceuticals Terminate Merger Agreement
November 30, 2012
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) and privately held Presidio Pharmaceuticals, Inc. today announced the mutual termination of the Merger Agreement and the related Investor Financing...
Read More
category
Management
,
Benzinga
,
BCRX
, and 4 more.
from
Latest Articles from Benzinga.com
BioCryst (BCRX), Presidio Announce Termination of Merger
November 30, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7913481 for the full story.
Read More
from
StreetInsider.com News Articles
Downgrade Alert for BioCryst Pharmaceuticals (BCRX)
November 28, 2012
from
Comtex SmarTrend® News Briefs
JMP Securities Downgrades BioCryst Pharma (BCRX) to Market Perform
November 27, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7905237 for the full story.
Read More
from
StreetInsider.com News Articles
BioCryst Pharma's (BCRX) BCX4161 Put on Clinical Hold by FDA
November 27, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7903655 for the full story.
Read More
from
StreetInsider.com News Articles
Hot Stock: BioCryst Pharmaceuticals, Shares Gain 9.5% (BCRX)
November 19, 2012
from
Comtex SmarTrend® News Briefs
BioCryst Pharmaceuticals Down 7.0%, Shares Slide into the Red (BCRX)
November 16, 2012
from
Comtex SmarTrend® News Briefs
Watch for Continued Losses in Shares of BioCryst Pharmaceuticals (BCRX)
November 16, 2012
from
Comtex SmarTrend® News Briefs
Hot Stock: BioCryst Pharmaceuticals, Shares Drop 5.9% (BCRX)
November 12, 2012
from
Comtex SmarTrend® News Briefs
BioCryst (BCRX) Issues Encouraging Update for BCX4430 on Yellow Fever
November 12, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7865010 for the full story.
Read More
from
StreetInsider.com News Articles
Top 10 Winners and Lowers for Q3 Earnings Season
November 09, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7862829 for the full story.
Read More
from
StreetInsider.com News Articles
BioCryst Pharmaceuticals: The Losing Streak Continues (BCRX)
November 09, 2012
from
Comtex SmarTrend® News Briefs
BioCryst Pharmaceuticals Ends Trial
November 08, 2012
BioCryst Pharmaceuticals Inc. (Nasdaq: BCRX) terminated a Phase 3 trial of its serious influenza treatment peramivir. The stock price plunged 99 cents to close at $1.46....
Read More
from
MarketMinute.com Stock News
Unusual 11 Mid-Day Movers 11/08: (DUSA) (RST) (PRMW) Higher; (CPRX) (BCRX) (PRSS) Lower
November 08, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7858270 for the full story.
Read More
from
StreetInsider.com News Articles
Stock to Watch: BioCryst Pharmaceuticals Down 42.7% (BCRX)
November 08, 2012
from
Comtex SmarTrend® News Briefs
BioCryst (BCRX) plummets on dismal outlook
November 08, 2012
Normal 0 false false false MicrosoftInternetExplorer4 BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) shares fell 44.1% to $1.37. The company early Thursday released an updated financial and business...
Read More
from
BAYSTREET RSS FEED
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here